Jackson, W. C., Dess, R. T., Jia, A. Y., Nagar, H., Desai, N. B., Hannan, R., Hearn, J. W., Reichert, Z. R., Marciscano, A. E., Davis, B., Zuhour, R., Zaorsky, N. G., Garcia, J. A., Barata, P. C., Brown, J. R., Mendiratta, P., Feng, F. Y., Chinnaiyan, A., Suresh, K., Spratt, D. E. (2025). Androgen suppression with abiraterone acetate, leuprolide, PARP inhibition, and stereotactic body radiotherapy (ASCLEPIuS) in high-risk and node positive prostate cancer (PCa): Phase I multicenter results.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.387